Recomendaciones actualizadas | 14 OCT 13

Infecciones necrotizantes de los tejidos blandos

Una enfermedad infrecuente pero de elevada mortalidad directamente relacionada con el retardo en iniciar el tratamiento.
Autor/a: Dres. Qaali A. Hussein, Daniel A. Anaya Crit Care Clin - (2013)
INDICE:  1.  | 2. Referencias

1. Sarani B, Strong M, Pascual J, et al. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg 2009;208(2):279–88.
2. Jones J. Surgical memoirs of the War of the Rebellion. In: Hamilton FH, editor. Investigation upon the nature, causes and treatment of hospital gangrene as prevailed in the Confederate Armies 1861-1865. New York: U.S. Sanitary Commission;1871.
3. Anaya DA, Bulger EM, Kwon YS, et al. Predicting death in necrotizing soft tissue infections: a clinical score. Surg Infect (Larchmt) 2009;10(6):517–22.
4. Anaya DA, McMahon K, Nathens AB, et al. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg 2005;140(2):151–7.
5. Wilson B. Necrotizing fasciitis. Am Surg 1952;18(4):416–31.
6. Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 2007;44(5):705–10.
7. Ellis Simonsen SM, van Orman ER, Hatch BE, et al. Cellulitis incidence in a defined population. Epidemiol Infect 2006;134(2):293–9.
8. Anaya DA, Dellinger EP. Necrotizing soft-tissue infection. In: Jong EC, Stevens DL, editors. Netter’s infectious disease. 1st edition. Philadelphia: Saunders; 2012. p. 273–8.
9. Callahan TE, SchecterWP, Horn JK. Necrotizing soft tissue infection masquerading as cutaneous abscess following illicit drug injection. Arch Surg 1998;133(8):812–7.
10. Chen JL, Fullerton KE, Flynn NM. Necrotizing fasciitis associated with injection drug use. Clin Infect Dis 2001;33(1):6–15.
11. Bosshardt TL, Henderson VJ, Organ CH Jr. Necrotizing soft-tissue infections. Arch Surg 1996;131(8):846–52.
12. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005;41(10):1373–406.
13. Haywood CT, McGeer A, Low DE. Clinical experience with 20 cases of group A streptococcus necrotizing fasciitis and myonecrosis: 1995 to 1997. Plast Reconstr Surg 1999;103(6):1567–73.
14. Elliott DC, Kufera JA, Myers RA. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg 1996;224(5):672–83.
15. Wong CH, Chang HC, Pasupathy S, et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 2003;85-A(8):1454–60.
16. Wong CH, Wang YS. The diagnosis of necrotizing fasciitis. Curr Opin Infect Dis 2005;18(2):101–6.
17. Wall DB, Klein SR, Black S, et al. A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. J AmColl Surg 2000;191(3):227–31.
18. Wong CH, Khin LW, Heng KS, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 2004;32(7):1535–41.
19. Holland MJ. Application of the Laboratory Risk Indicator in Necrotising Fasciitis (LRINEC) score to patients in a tropical tertiary referral centre. Anaesth Intensive Care 2009;37(4):588–92.
20. Wysoki MG, Santora TA, Shah RM, et al. Necrotizing fasciitis: CT characteristics. Radiology 1997;203(3):859–63.
21. Struk DW, Munk PL, Lee MJ, et al. Imaging of soft tissue infections. Radiol Clin North Am 2001;39(2):277–303.
22. Arslan A, Pierre-Jerome C, Borthne A. Necrotizing fasciitis: unreliable MRI findings in the preoperative diagnosis. Eur J Radiol 2000;36(3):139–43.
23. Stamenkovic I, Lew PD. Early recognition of potentially fatal necrotizing fasciitis. The use of frozen-section biopsy. N Engl J Med 1984;310(26):1689–93.
24. Majeski J, Majeski E. Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J 1997;90(11):1065–8.
25. May AK. Skin and soft tissue infections: the new surgical infection society guidelines. Surg Infect (Larchmt) 2011;12(3):179–84.
26. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005;352(14):1445–53.
27. Marshall JC, Maier RV, Jimenez M, et al. Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit Care Med 2004; 32(Suppl 11):S513–26.
28. Eagle H. Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med 1952;13(4):389–99.
29. Stevens DL, Gibbons AE, Bergstrom R, et al. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988;158(1):23–8.
30. Zimbelman J, Palmer A, Todd J. Improved  outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 1999;18(12):1096–100.
31. Mulla ZD, Leaverton PE, Wiersma ST. Invasive group A streptococcal infections in Florida. South Med J 2003;96(10):968–73.
32. Stevens DL, Bryant AE, Hackett SP. Antibiotic effects on bacterial viability, toxin production, and host response. Clin Infect Dis 1995;20(Suppl 2):S154–7.
33. McHenry CR, Piotrowski JJ, Petrinic D, et al. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 1995;221(5):558–63.
34. Bilton BD, Zibari GB, McMillan RW, et al. Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am Surg 1998;64(5):397–400.
35. Lille ST, Sato TT, Engrav LH, et al. Necrotizing  soft tissue infections: obstacles in diagnosis. J Am Coll Surg 1996;182(1):7–11.
36. Phan HH, Cocanour CS. Necrotizing soft tissue infections in the intensive care unit. Crit Care Med 2010;38(Suppl 9):S460–8.
37. Ustin JS, Malangoni MA. Necrotizing soft-tissue infections. Crit Care Med 2011; 39(9):2156–62.
38. Riseman JA, Zamboni WA, Curtis A, et al. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery 1990;108(5):847–50.
39. Jallali N, Withey S, Butler PE. Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. Am J Surg 2005;189(4):462–6.
40. Kaul R, McGeer A, Norrby-Teglund A, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome–a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 1999;28(4):800–7.
41. Darenberg J, Ihendyane N, Sjolin J, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003;37(3):333–40.
42. Norrby-Teglund A, Muller MP, McGeer A, et al. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand J Infect Dis 2005;37(3):166–72.
43. Pham TN, Moore ML, Costa BA, et al. Assessment of functional limitation after necrotizing soft tissue infection. J Burn Care Res 2009;30(2):301–6.
44. Endorf FW, Klein MB, Mack CD, et al. Necrotizing soft-tissue infections: differences in patients treated at burn centers and non-burn centers. J Burn Care Res 2008;29(6):933–8.12



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022